GlassScriptPhysician profile
Steven R Anderson
NPI 1295853018
$36,973.29
in general payments reported to CMS, 2019-2025
24 companies · $100 in 2025
The $100 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $206 · 2021: $1,095 · 2023: $193 · 2024: $300 · 2025: $100.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $594.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integrity Implants INC. | $34,716.38 | 2019 | |
| Smith+Nephew, INC. | $1,078.32 | 2019-2024 | Journey II, Real Intelligence |
| Depuy Synthes Sales INC. | $201.10 | 2019-2021 | |
| Medacta USA, INC. | $183.01 | 2019-2024 | |
| Peerless Surgical INC. | $112.36 | 2020 | |
| Medical Device Business Services, INC. | $77.88 | 2021 | |
| Vericel Corporation | $73.60 | 2019 | |
| Stryker Corporation | $70.50 | 2025 | Tritanium, Mako |
| Piedmont Plus Innovation | $62.13 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $58.12 | 2024 | Exparel, Zilretta, Iovera |
| Ferring Pharmaceuticals INC. | $49.70 | 2023-2024 | Euflexxa |
| Novo Nordisk INC | $34.62 | 2023 | Wegovy, Saxenda |
| Zimmer Biomet Holdings, INC. | $33.84 | 2020-2023 | Tricera Handpiece |
| Vertex Pharmaceuticals Incorporated | $29.91 | 2025 | |
| Medtronic, INC. | $24.94 | 2024 | Intellis Adaptivestim |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $22.28 | 2019 | |
| Radius Health, INC. | $20.58 | 2019 | |
| Ipsen Biopharmaceuticals, INC | $20.16 | 2023 | Dysport |
| Kinex Medical Company LLC | $20.00 | 2019-2020 | |
| Bioventus LLC | $19.90 | 2019 | |
| Molnlycke Health Care US, LLC | $19.31 | 2023 | Mepilex Border Sacrum, Mepilex Border Post-Op Ag, Mepilex Border Post-Op |
| Amgen INC. | $17.26 | 2024 | |
| Horizon Therapeutics Plc | $14.98 | 2023 | Krystexxa |
| Pfizer INC. | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.